Biogen Inc (BIIB)

BIIB (NASDAQ:Drugs) EQUITY
$404.28
pos +0.00
+0.00%
Today's Range: 403.15 - 407.98 | BIIB Avg Daily Volume: 1,564,900
Last Update: 07/02/15 - 3:59 PM EDT
Volume: 0
YTD Performance: 19.10%
Open: $0.00
Previous Close: $405.41
52 Week Range: $290.85 - $480.18
Oustanding Shares: 235,229,512
Market Cap: 95,098,587,111
6-Month Chart
TheStreet Ratings Grade for BIIB
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 9 9 10 9
Moderate Buy 2 2 2 1
Hold 7 6 6 4
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.86 1.79 1.75 1.64
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 29.21
Price Earnings Comparisons:
BIIB Sector Avg. S&P 500
29.21 29.20 26.10
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-1.98% 22.14% 177.65%
GROWTH 12 Mo 3 Yr CAGR
Revenue 46.50 0.92 0.24
Net Income 57.90 1.32 0.32
EPS 58.30 1.44 0.34
Earnings for BIIB:
EBITDA 3.41B
Revenue 8.51B
Average Earnings Estimates
Qtr (06/15) Qtr (09/15) FY (12/15) FY (12/16)
Average Estimate $4.07 $4.28 $16.59 $19.21
Number of Analysts 11 11 13 13
High Estimate $4.26 $4.40 $16.96 $20.39
Low Estimate $3.91 $4.12 $16.16 $18.02
Prior Year $3.49 $3.79 $13.79 $16.59
Growth Rate (Year over Year) 16.59% 13.00% 20.32% 15.77%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Jim Cramer

 | Jun 29, 2015 | 12:10 PM EDT

Jim Cramer answers viewers' Twitter (TWTR) questions from the floor of the New York Stock Exchange.

bearishBiogen estimates, target reduced at Leerink

Jun 11, 2015 | 7:45 AM EDT

BIIB estimates were cut through 2016, Leerink Partners said. Company is seeing lower Tecfidera trends. Outperform rating and new $512 price target. 

updateBIIB Investor Mtg.

Jun 10, 2015 | 6:52 AM EDT

BIIB - Biogen Inc Annual Shareholders Meeting - 9AM

By

David Peltier

 | Jun 9, 2015 | 4:37 PM EDT

Averages end mixed; Lululemon has big day.

By

Jim Cramer

 | Jun 4, 2015 | 11:40 AM EDT

Jim Cramer answers viewers' Twitter (TWTR) questions from the floor of the New York Stock Exchange.

By

Jim Cramer

 | May 27, 2015 | 3:47 PM EDT

Buy at right price and have courage to hold.

By

Jim Cramer

 | May 21, 2015 | 12:21 PM EDT

Jim Cramer answers viewers' Twitter (TWTR) questions from the floor of the New York Stock Exchange.

By

Jim Cramer

 | May 18, 2015 | 12:19 PM EDT

Many of these stocks are off to the races.

By

Jim Cramer

 | May 13, 2015 | 11:17 AM EDT

Jim Cramer answers viewers' stock questions from the floor of the New York Stock Exchange.

By

Jim Cramer

 | May 6, 2015 | 1:33 PM EDT

It's not the Fed chief's place.

If the adage that the market hates uncertainty, then a "yes" vote just brings further nego...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.